METASTATIC COLORECTAL CANCER (CRC)
Clinical trials for METASTATIC COLORECTAL CANCER (CRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (CRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced colon cancer patients after standard treatments fail
Disease control Not yet recruitingThis study tests whether reusing a previous drug combination (irinotecan plus cetuximab) works better than the current standard treatment for advanced colorectal cancer that has worsened after two rounds of therapy. Researchers will enroll 150 patients whose cancer has specific g…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italia Meridionale • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat colon cancer patients
Disease control Not yet recruitingThis study is comparing two different drug combinations for people with advanced colorectal cancer that has spread and stopped responding to standard chemotherapy. Researchers want to see if adding fruquintinib to chemotherapy works better or is safer than adding bevacizumab to t…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug combo trial targets four tough digestive cancers
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called SSGJ-706 to standard first-line chemotherapy can better control advanced cancers of the stomach, colon, pancreas, and esophagus. It will enroll about 300 adults with these cancers who have not yet received treatment…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Four-Drug attack on advanced colon cancer begins human testing
Disease control Not yet recruitingThis study is testing a new combination of four drugs as the first treatment for advanced colorectal cancer that cannot be removed by surgery. It will enroll 70 patients who have not had prior cancer drug treatment. The main goal is to see how well the tumors shrink and how long …
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Four-Drug attack on advanced colon cancer launches trial
Disease control Not yet recruitingThis study is testing a new combination of four existing drugs for people with metastatic colorectal cancer that has continued to grow after their first treatment. The goal is to see if this four-drug mix can better control the cancer's growth, extend the time patients live witho…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC